Abstract
Background
Hematoma after non-oncologic breast surgery is a common concern requiring expeditious treatment. The purpose of this study is to perform an evidence-based review of perioperative factors that may contribute to hematoma in non-oncologic breast procedures.
Methods
A comprehensive literature review was performed of non-oncologic breast procedures: breast augmentation, single-stage augmentation-mastopexy, mastopexy, and reduction. In total, 28 studies highlighting incidence and potential risk factors for hematoma were included; overall level of evidence was established regarding each perioperative factor examined and hematoma rate.
Results
The hematoma rate in breast augmentation ranges from 0.2 to 5.7%. There is inconclusive evidence to support an association between pocket choice or incision location and hematoma rate (Level III) and no evidence of an association between implant type and hematoma (Level V). Single-stage augmentation-mastopexy may have a lower hematoma rate than augmentation alone (Level II). Hematoma may increase the risk of capsular contracture (Level III). In breast reduction, the hematoma rate ranges from 1.0 to 9.3%. Evidence of an association between incision choice and hematoma rate is inconclusive (Level III). Use of epinephrine-containing solution, pedicle choice, and resection weight do not appear to affect hematoma rate (Level V, II, and II, respectively). The use of postoperative drains and ketorolac do not affect the incidence of hematoma (Level I and III, respectively). Intraoperative hypotension may increase the risk of hematoma after breast reduction (Level III).
Conclusions
Breast hematomas are not uncommon complications. Current literature lacks ample evidence for risk factors for hematoma after non-oncologic breast procedures, warranting further, high-powered investigations.
Level of Evidence III
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
Similar content being viewed by others
References
Society TA (2020) ASAPS Quick Facts: Highlights of the 2019 Stats
Surgeons ASoP (2019). 2019 Plastic Surgery Statistics Report
Kaoutzanis C, Winocour J, Gupta V, Ganesh Kumar N, Sarosiek K, Wormer B et al (2017) Incidence and risk factors for major hematomas in aesthetic surgery: analysis of 129,007 patients. Aesthet Surg J 37(10):1175–1185
Sullivan D, Chung KC, Eaves FF 3rd, Rohrich RJ (2011) The level of evidence pyramid: indicating levels of evidence in plastic and reconstructive surgery articles. Plast Reconstr Surg 128(1):311–314
Diaz JF (2017) Review of 494 consecutive breast augmentation patients: system to improve patient outcomes and satisfaction. Plast Reconstr Surg Glob Open 5(10):e1526
Somogyi RB, Brown MH (2015) Outcomes in primary breast augmentation: a single surgeon’s review of 1539 consecutive cases. Plast Reconstr Surg 135(1):87–97
Tebbetts JB (2006) Axillary endoscopic breast augmentation: processes derived from a 28-year experience to optimize outcomes. Plast Reconstr Surg 118(7):53S-80S
Gabriel SE, Woods JE, O’Fallon WM, Beard CM, Kurland LT, Melton LJ 3rd (1997) Complications leading to surgery after breast implantation. N Engl J Med 336(10):677–682
Alderman AK, Collins ED, Streu R, Grotting JC, Sulkin AL, Neligan P et al (2009) Benchmarking outcomes in plastic surgery: national complication rates for abdominoplasty and breast augmentation. Plast Reconstr Surg 124(6):2127–2133
Khan UD (2013) Muscle-splitting, subglandular, and partial submuscular augmentation mammoplasties: a 12-year retrospective analysis of 2026 primary cases. Aesthet Plast Surg 37(2):290–302
Stutman RL, Codner M, Mahoney A, Amei A (2012) Comparison of breast augmentation incisions and common complications. Aesthet Plast Surg 36(5):1096–1104
Jacobson JM, Gatti ME, Schaffner AD, Hill LM, Spear SL (2012) Effect of incision choice on outcomes in primary breast augmentation. Aesthet Surg J. 32(4):456–462
Swanson E (2013) Prospective comparative clinical evaluation of 784 consecutive cases of breast augmentation and vertical mammaplasty, performed individually and in combination. Plast Reconstr Surg 132(1):30e–45e
Khavanin N, Jordan SW, Rambachan A, Kim JY (2014) A systematic review of single-stage augmentation-mastopexy. Plast Reconstr Surg 134(5):922–931
Kerrigan CL, Slezak SS (2013) Evidence-based medicine: reduction mammaplasty. Plast Reconstr Surg 132(6):1670–1683
Nguyen BN, Barta RJ, Stewart CE, Heinrich CA (2018) Toradol following breast surgery: is there an increased risk of hematoma? Plast Reconstr Surg 141(6):814e-e817
Firriolo JM, Nuzzi LC, Schmidtberg LC, Labow BI (2018) Perioperative ketorolac use and postoperative hematoma formation in reduction mammaplasty: a single-surgeon experience of 500 consecutive cases. Plast Reconstr Surg 142(5):632e-e638
Barkho JO, Li YK, Duku E, Thoma A (2018) Ketorolac may increase hematoma risk in reduction mammaplasty: a case-control study. Plast Reconstr Surg Glob Open 6(3):e1699
Fernandez S, Coady L, Cohen-Shohet R, Molas-Pierson J, Mast BA (2016) Comparative outcomes and quality analysis of inverted-T and pure vertical scar techniques in superomedial pedicle reduction mammaplasty. Ann Plast Surg 76(4):S328–S331
Ogunleye AA, Leroux O, Morrison N, Preminger AB (2017) Complications after reduction mammaplasty: a comparison of wise pattern/inferior pedicle and vertical scar/superomedial pedicle. Ann Plast Surg 79(1):13–16
Zoumaras J, Lawrence J (2008) Inverted-T versus vertical scar breast reduction: one surgeons 5-year experience with consecutive patients. Aesthet Surg J 28(5):521–526 ((discussion 6-7))
Greco R, Noone B (2017) Evidence-based medicine: reduction mammaplasty. Plast Reconstr Surg 139(1):230e-e239
Cruz-Korchin N, Korchin L (2003) Vertical versus wise pattern breast reduction: patient satisfaction, revision rates, and complications. Plast Reconstr Surg 112(6):1573–1578 ((d iscussion 9–81))
Wrye SW, Banducci DR, Mackay D, Graham WP, Hall WW (2003) Routine drainage is not required in reduction mammaplasty. Plast Reconstr Surg 111(1):113–117
Collis N, McGuiness CM, Batchelor AG (2005) Drainage in breast reduction surgery: a prospective randomised intra-patient trail. Br J Plast Surg 58(3):286–289
Corion LU, Smeulders MJ, van Zuijlen PP, van der Horst CM (2009) Draining after breast reduction: a randomised controlled inter-patient study. J Plast Reconstr Aesthet Surg 62(7):865–868
Srinivasaiah N, Iwuchukwu OC, Stanley PR, Hart NB, Platt AJ, Drew PJ (2014) Risk factors for complications following breast reduction: results from a randomized control trial. Breast J 20(3):274–278
Cunningham BL, Gear AJ, Kerrigan CL, Collins ED (2005) Analysis of breast reduction complications derived from the BRAVO study. Plast Reconstr Surg 115(6):1597–1604
Spector JA, Singh SP, Karp NS (2008) Outcomes after breast reduction: does size really matter? Ann Plast Surg 60(5):505–509
Lapid O, Pietersen L, van der Horst CM (2012) Reoperation for haematoma after breast reduction with preoperative administration of low-molecular-weight heparin: experience in 720 patients. J Plast Reconstr Aesthet Surg 65(11):1513–1517
Collins JB, Verheyden CN (2012) Incidence of breast hematoma after placement of breast prostheses. Plast Reconstr Surg 129(3):413e-e420
Gupta V, Yeslev M, Winocour J, Bamba R, Rodriguez-Feo C, Grotting JC et al (2017) Aesthetic breast surgery and concomitant procedures: incidence and risk factors for major complications in 73,608 cases. Aesthet Surg J 37(5):515–527
Stevens WG, Macias LH, Spring M, Stoker DA, Chacon CO, Eberlin SA (2014) One-stage augmentation mastopexy: a review of 1192 simultaneous breast augmentation and mastopexy procedures in 615 consecutive patients. Aesthet Surg J 34(5):723–732
Hubbard TJ (2019) Vertical augmentation mastopexy with implant isolation and tension management. Plast Reconstr Surg Glob Open 7(6):e2226
Artz JD, Tessler O, Clark S, Patel S, Torabi R, Moses M (2019) Can it be safe and aesthetic? an eight-year retrospective review of mastopexy with concurrent breast augmentation. Plast Reconstr Surg Glob Open 7(6):e2272
Calobrace MB, Stevens WG, Capizzi PJ, Cohen R, Godinez T, Beckstrand M (2018) Risk factor analysis for capsular contracture: a 10-year sientra study using round, smooth, and textured implants for breast augmentation. Plast Reconstr Surg 141:20S–8S
Codner MA, Mejia JD, Locke MB, Mahoney A, Thiels C, Nahai FR et al (2011) A 15-year experience with primary breast augmentation. Plast Reconstr Surg. 127(3):1300–1310
Hidalgo DA, Weinstein AL (2020) Surgical treatment for capsular contracture: a new paradigm and algorithm. Plast Reconstr Surg 146(3):516–525
Rancati A, Irigo M, Angrigiani C (2016) Management of the ischemic nipple-areola complex after breast reduction. Clin Plast Surg 43(2):403–414
Ramanadham SR, Costa CR, Narasimhan K, Coleman JE, Rohrich RJ (2015) Refining the anesthesia management of the face-lift patient: lessons learned from 1089 consecutive face lifts. Plast Reconstr Surg 135(3):723–730
Ramanadham SR, Mapula S, Costa C, Narasimhan K, Coleman JE, Rohrich RJ (2015) Evolution of hypertension management in face lifting in 1089 patients: optimizing safety and outcomes. Plast Reconstr Surg 135(4):1037–1043
Auersvald A, Auersvald LA (2014) Hemostatic net in rhytidoplasty: an efficient and safe method for preventing hematoma in 405 consecutive patients. Aesthetic Plast Surg 38(1):1–9
Ballan A, Jabbour S, El Rayess Y, Jabbour K, El Hachem L, Nasr M (2020) Quilting sutures in rhytidectomy: a systematic review of the literature. Aesthet Surg J 40(11):1157–1164
Cohen JC, Glasgold RA, Alloju LM, Glasgold MJ (2020) Effects of intravenous tranexamic acid during rhytidectomy: a randomized, controlled, double-blind pilot study. Aesthet Surg J. https://doi.org/10.1093/asj/sjaa072
Kochuba AL, Coombs DM, Kwiecien GJ, Sinclair NR, Zins JE (2020) Prospective study assessing the effect of local infiltration of tranexamic acid on facelift bleeding. Aesthet Surg J. https://doi.org/10.1093/asj/sjaa198
Ausen K, Fossmark R, Spigset O, Pleym H (2015) Randomized clinical trial of topical tranexamic acid after reduction mammoplasty. Br J Surg 102(11):1348–1353
Ausen K, Hagen AI, Ostbyhaug HS, Olafsson S, Kvalsund BJ, Spigset O et al (2020) Topical moistening of mastectomy wounds with diluted tranexamic acid to reduce bleeding: randomized clinical trial. BJS Open 4(2):216–224
Weissler JM, Banuelos J, Jacobson SR, Manrique OJ, Nguyen MT, Harless CA et al (2020) Intravenous tranexamic acid in implant-based breast reconstruction safely reduces hematoma without thromboembolic events. Plast Reconstr Surg 146(2):238–245
Henry SL, Crawford JL, Puckett CL (2009) Risk factors and complications in reduction mammaplasty: novel associations and preoperative assessment. Plast Reconstr Surg 124(4):1040–1046
Hussien M, Lee S, Malyon A, Norrie J, Webster M (2001) The impact of intraoperative hypotension on the development of wound haematoma after breast reduction. Br J Plast Surg 54(6):517–522
Pedron M (2005) Minimal-scar breast reduction and mastopexy. Aesthetic Plast Surg 29(4):261–273
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to disclose.
Human or Animal Rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Daar, D.A., Bekisz, J.M., Chiodo, M.V. et al. Hematoma After Non-Oncologic Breast Procedures: A Comprehensive Review of the Evidence. Aesth Plast Surg 45, 2602–2617 (2021). https://doi.org/10.1007/s00266-021-02276-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-021-02276-6